146 related articles for article (PubMed ID: 1801235)
21. [24-hour blood pressure monitoring. Results with captopril once a day].
Puhlmann WH; Strüder P
Fortschr Med; 1990 Nov; 108(34):660-2. PubMed ID: 2289738
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the hypotensive effect of captopril in patients with severe and treatment-resistant arterial hypertension].
Grajek S; Paradowski S; Kozłowska F; Gracz M
Kardiol Pol; 1988; 31(8):515-22. PubMed ID: 3072437
[No Abstract] [Full Text] [Related]
23. Chronobiologic assessment of antihypertensive therapy.
Tamura K; Kohno I; Tsuruta I; Ijiri H; Nakamura T
Ann Ist Super Sanita; 1993; 29(4):693-704. PubMed ID: 7985930
[TBL] [Abstract][Full Text] [Related]
24. [Amlodipine in long-term treatment of mild and moderate hypertension. A multicenter study].
Sauerbrey-Wullkopf N; Anlauf M
Fortschr Med; 1995 Feb; 113(5):58-62. PubMed ID: 7721221
[TBL] [Abstract][Full Text] [Related]
25. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
26. [A comparison of the effect of Capoten (captopril) and ramipril on the circadian profile of the arterial pressure and peripheral hemodynamics in patients with hypertension combined with diabetes mellitus].
Filatova EV; Vikhert OA; Rogoza AN; Arabidze GG; Kukharchuk VV
Ter Arkh; 1996; 68(5):67-70. PubMed ID: 9082606
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the cardiac and peripheral vascular effects of the administration of single-dose enalapril and captopril in essential arterial hypertension].
Longhini C; Ansani L; Musacci GF; Vaccari M; Fraccaroli GP; Mele D; Aggio S; Baracca E
Cardiologia; 1989 Jan; 34(1):61-7. PubMed ID: 2541907
[TBL] [Abstract][Full Text] [Related]
28. Ramipril vs captopril in mild to moderate hypertension.
Yajnik VH; Vatsraj DJ; Acharya HK; Yajnik NV; Vyas NR; Vakil HB
J Assoc Physicians India; 1994 Feb; 42(2):120-3. PubMed ID: 7860471
[TBL] [Abstract][Full Text] [Related]
29. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH; Burgess ED; Assouline L; Vanjaka A
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[TBL] [Abstract][Full Text] [Related]
30. [Possibilities of the control of arterial hypertension using the step-by-step schedule of long-term treatment with antihypertensive drugs. The Working Group on the Study of New Drugs for the Prevention of Arterial Hypertension].
Ter Arkh; 1988; 60(1):118-23. PubMed ID: 3363497
[TBL] [Abstract][Full Text] [Related]
31. [Multicenter study with 3 different doses of ketanserin in essential arterial hypertension].
Cruz J; Moscovici H; Silva AN; Finkielman S; Milei J; Geyer G; Feltkamp H; Stumpe KO; Berges LC
Arq Bras Cardiol; 1985 Oct; 45(4):299-304. PubMed ID: 2940997
[No Abstract] [Full Text] [Related]
32. [Sublingual captopril: indications and advantages?].
Meyer GJ
Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S4. PubMed ID: 10818992
[No Abstract] [Full Text] [Related]
33. Antianxiety treatment in patients with excessive hypertension.
Grossman E; Nadler M; Sharabi Y; Thaler M; Shachar A; Shamiss A
Am J Hypertens; 2005 Sep; 18(9 Pt 1):1174-7. PubMed ID: 16182105
[TBL] [Abstract][Full Text] [Related]
34. [Long term treatment of resistant hypertension with captopril (author's transl)].
Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
[TBL] [Abstract][Full Text] [Related]
35. [Captopril from Pharmachem in the treatment of arterial hypertension].
Monova D; Belovezhdov N
Vutr Boles; 1989; 28(3):40-3. PubMed ID: 2672594
[TBL] [Abstract][Full Text] [Related]
36. [Long-term effects of captopril treatment on the course of stable effort angina pectoris and structural-functional characteristics of platelets in patients with hypertension and ischemic heart disease].
Shafer MZh; Gul'tiaeva EP; Gapon LI; Alfimova TV
Ter Arkh; 2001; 73(7):64-7. PubMed ID: 11523414
[TBL] [Abstract][Full Text] [Related]
37. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
Middeke M; Richter WO; Schwandt P; Holzgreve H
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
[TBL] [Abstract][Full Text] [Related]
38. Blood pressure characteristics of hypertensive patients in Austria as determined by self-monitoring (SCREEN-II).
Hitzenberger G; Magometschnigg D
Blood Press; 2003; 12(3):134-8. PubMed ID: 12875473
[TBL] [Abstract][Full Text] [Related]
39. [Do clinical parameters exist that permit predicting the need to combine a diuretic with captopril in the initial treatment of essential arterial hypertension?].
Coca A; de la Sierra A; Sobrino J; Aguilera MT; Closas J; Sánchez M; Urbano-Márquez A
Rev Clin Esp; 1990 Nov; 187(8):383-8. PubMed ID: 2091131
[TBL] [Abstract][Full Text] [Related]
40. [Should hypotensive treatment be continued for the rest of the patient's life?].
Januszewicz W; Chodakowska J
Kardiol Pol; 1992; 36(1):40-2. PubMed ID: 1583822
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
